# Charles V. Pollack

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/charles-v-pollack/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,779 |
| Field | Acute Myocardial Infarction Research |
| h-index | 76 |
| i10-index | 217 |
| Last Known Institution | University of Mississippi |
| OpenAlex ID | https://openalex.org/A5048154042 |
| ORCID iD | https://orcid.org/0000-0002-1214-7881 |
| Works | 498 |

## Researcher papers

- [Idarucizumab for Dabigatran Reversal](https://scholariq.org/papers/idarucizumab-for-dabigatran-reversal/)
- [Intravenous Platelet Blockade with Cangrelor during PCI](https://scholariq.org/papers/intravenous-platelet-blockade-with-cangrelor-during-pci/)
- [Platelet Inhibition with Cangrelor in Patients Undergoing PCI](https://scholariq.org/papers/platelet-inhibition-with-cangrelor-in-patients-undergoing-pci/)
- [Clinical Characteristics, Management, and Outcomes of Patients Diagnosed With Acute Pulmonary Embolism in the Emergency Department](https://scholariq.org/papers/clinical-characteristics-management-and-outcomes-of-patients-diagnosed-with/)

## Researcher topics

- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management-2/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)

## Researcher university

- [University of Mississippi](https://scholariq.org/institutions/university-of-mississippi/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.